Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Gynecologic Cancer: early-phase trial registry
27 of 56 indexed Gynecologic Cancer trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #252 of 28,707 conditions by registered trial count.
56 US clinical trials · 27 currently recruiting · #252 of 28,707 conditions by registered trial count
Gynecologic Cancer: 56 US clinical trials tracked, 27 recruiting.
Gynecologic Cancer is the subject of 56 registered US clinical trials on ClinicalTrials.gov, 27 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 16 in Phase 1-2 (earlier-stage). The most active sponsor is Dana-Farber Cancer Institute, running 6 of these trials.
Enrollment posture brief
Registry condition gynecologic-cancer
OPEN 27 | RECR 48% | LATE 2 | EARLY 16 | RANK #252 | SPON 6
Volume-matched condition peers
Nearest open-share peer: Advanced Solid Tumors (48% recruiting · 145 trials)
Gynecologic Cancer lists 27 open slots (48% of 56 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Gynecologic Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Gynecologic Cancer is recruiting above its size-band peers.
27 of 56 indexed trials (48.2%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Gynecologic Cancer trials is spread across many organizations.
Dana-Farber Cancer Institute accounts for 6 of 56 trials (10.7%). 37 distinct sponsors appear on at least one study for this condition label.
-
Most Gynecologic Cancer trials plan to enrol fewer than 100 people.
Median target enrolment is 60 among the 56 trials that report a genuine target (sentinel values excluded). 34 of those (60.7%) plan for fewer than 100 participants.
-
Gynecologic Cancer research is mostly interventional.
46 interventional and 10 observational studies make up this index (82.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
56 total, page 2 of 2
The HOPE Trial and the SMART Study
Dana-Farber Cancer Institute
NCT03022032
Improving Quality of Life Using Patient Reported Outcomes Measures Post-operative Via Text Messaging
University of Michigan Rogel Cancer Center
NCT04852471
Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery
University of Wisconsin, Madison
NCT01444924
Women's Health Communication Study
Fox Chase Cancer Center
NCT05359952
Developing a Psychosexual Educational Partners Program: PEPP A Feasibility Study
University of Michigan Rogel Cancer Center
NCT05070299
[18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers
Abramson Cancer Center at Penn Medicine
NCT02108457
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 10 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Gynecologic Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Gynecologic Cancer trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Gynecologic Cancer page
56 registered trials, 27 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 27 Gynecologic Cancer trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Dana-Farber Cancer Institute sponsors the most Gynecologic Cancer trials on record, review their full trial history before evaluating a specific study. See Dana-Farber Cancer Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Gynecologic Cancer condition card totals 56 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.